Cargando…
Bacteroides fragilis Prevents Clostridium difficile Infection in a Mouse Model by Restoring Gut Barrier and Microbiome Regulation
Clostridium difficile is currently the leading cause of nosocomial infection. Antibiotics remain the first-line therapy for C. difficile-associated diseases (CDAD), despite the risks of resistance promotion and further gut microbiota perturbation. Notably, the abundance of Bacteroides fragilis was r...
Autores principales: | Deng, Huimin, Yang, Siqi, Zhang, Yucheng, Qian, Kai, Zhang, Zhaohui, Liu, Yangyang, Wang, Ye, Bai, Yang, Fan, Hongying, Zhao, Xinmei, Zhi, Fachao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308121/ https://www.ncbi.nlm.nih.gov/pubmed/30619112 http://dx.doi.org/10.3389/fmicb.2018.02976 |
Ejemplares similares
-
Corrigendum: Bacteroides fragilis Prevents Clostridium difficile Infection in a Mouse Model by Restoring Gut Barrier and Microbiome Regulation
por: Deng, Huimin, et al.
Publicado: (2019) -
Safety Evaluation of a Novel Strain of Bacteroides fragilis
por: Wang, Ye, et al.
Publicado: (2017) -
In vivo Imaging of a Novel Strain of Bacteroides fragilis via Metabolic Labeling
por: Xu, Wenye, et al.
Publicado: (2018) -
Bioluminescence Imaging to Track Bacteroides fragilis Inhibition of Vibrio parahaemolyticus Infection in Mice
por: Li, Zhengchao, et al.
Publicado: (2017) -
A novel strain of Bacteroides fragilis enhances phagocytosis and polarises M1 macrophages
por: Deng, Huimin, et al.
Publicado: (2016)